Results 131 to 140 of about 27,037 (216)

Daptomycin-Induced Pulmonary Toxicity: A Case Series.

open access: yes, 2023
Daptomycin is a bactericidal antibiotic used to treat methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococcus (VRE). Eosinophilic pneumonia is an uncommon but significant adverse effect of daptomycin.
Natarajan, Sarasija   +3 more
core  

De Novo Daptomycin-Nonsusceptible Enterococcal Infections

open access: yes, 2012
Potential emergence of enterococcal daptomycin nonsusceptibility among patients with no prior exposure to daptomycin poses clinical and public health challenges.
Daniel Z. Uslan   +3 more
core   +1 more source

Daptomycin Nonsusceptible Enterococci: An Emerging Challenge for Clinicians

open access: yes, 2011
Daptomycin is the only antibiotic with in vitro bactericidal activity against vancomycin-resistant Enterococcus (VRE) that is approved by the Food and Drug Administration (FDA).
David A. Pegues   +3 more
core   +1 more source

Treatment outcomes of daptomycin- and vancomycin-resistant <i>Enterococcus faecium</i> bloodstream infection. [PDF]

open access: yesJAC Antimicrob Resist
Lin WT   +7 more
europepmc   +1 more source

Ceftaroline for Methicillin-Resistant Staphylococcus aureus Endovascular Infection. [PDF]

open access: yesInfect Dis Ther
Cosimi RA   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy